-
公开(公告)号：US20250042883A1
公开(公告)日：2025-02-06
申请号：US18830194
申请日：2024-09-10
Applicant: QILU REGOR THERAPEUTICS INC.
Inventor： Wenge ZHONG , Wei GUO
IPC: C07D405/14 , C07D417/14 , C07D471/04
Abstract: The present disclosure provides compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
Search Results
1
records
(took 0.017 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
